Disorders of glyoxylate metabolism (Q40061): Difference between revisions
From determinar.ia.br - Determine suas informações
Created a new Item |
Changed an Item |
||||||||||||||
| (7 intermediate revisions by the same user not shown) | |||||||||||||||
| description / pt-br | description / pt-br | ||||||||||||||
Hiperoxalúria primária ou oxalose, é um transtorno metabólico raro, transmitido como uma doença autossômica recessiva ,subdividida em 2 tipos: tipo 1 que é mais frequente e tipo 2, que é extremamente rara. A hiperoxalúria tipo 1 é devido a um defeito numa enzima hepática peroxissomal alanina glioxilato aminotransferase. A hiperoxalúria tipo 2 é extremamente rara e é devida a deficiência de glicerato desidroginase. | |||||||||||||||
| description / en | description / en | ||||||||||||||
Primary hyperoxaluria, or oxalosis, is a rare metabolic disorder transmitted as an autosomal recessive disease, including both type 1, the most frequent, and type 2, extremely rare. Hyperoxaluria type 1 is due to a defect of the peroxysomal hepatic enzyme L-alanine: glyoxylate aminotransferase (AGT). Hyperoxaluria type 2 is extremely rare and is due to glycerate dehydrogenase deficiency. | |||||||||||||||
| Property / Canonical URI | |||||||||||||||
| Property / Canonical URI: https://id.who.int/icd/entity/1800430868 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / CURIE | |||||||||||||||
CID11:5C51.2 | |||||||||||||||
| Property / CURIE: CID11:5C51.2 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Canary Token | |||||||||||||||
dki-india-5C51.2 | |||||||||||||||
| Property / Canary Token: dki-india-5C51.2 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Verification Status | |||||||||||||||
Concluído | |||||||||||||||
| Property / Verification Status: Concluído / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Knowledge Architect | |||||||||||||||
| Property / Knowledge Architect: https://pauloleads.com.br/cases-publicos/ / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Collection date | |||||||||||||||
13 August 2026
| |||||||||||||||
| Property / Collection date: 13 August 2026 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Linked ICD 10 | |||||||||||||||
| Property / Linked ICD 10: E74.9 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Latest revision as of 05:43, 13 August 2026
Primary hyperoxaluria, or oxalosis, is a rare metabolic disorder transmitted as an autosomal recessive disease, including both type 1, the most frequent, and type 2, extremely rare. Hyperoxaluria type 1 is due to a defect of the peroxysomal hepatic enzyme L-alanine: glyoxylate aminotransferase (AGT). Hyperoxaluria type 2 is extremely rare and is due to glycerate dehydrogenase deficiency.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | 5C51.2 |
||
| English | Disorders of glyoxylate metabolism |
Primary hyperoxaluria, or oxalosis, is a rare metabolic disorder transmitted as an autosomal recessive disease, including both type 1, the most frequent, and type 2, extremely rare. Hyperoxaluria type 1 is due to a defect of the peroxysomal hepatic enzyme L-alanine: glyoxylate aminotransferase (AGT). Hyperoxaluria type 2 is extremely rare and is due to glycerate dehydrogenase deficiency. |
Statements
CID11:5C51.2
0 references
dki-india-5C51.2
0 references
Concluído
0 references
13 August 2026
0 references
